These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20363922)

  • 21. Coordinate nuclear targeting of the FANCD2 and FANCI proteins via a FANCD2 nuclear localization signal.
    Boisvert RA; Rego MA; Azzinaro PA; Mauro M; Howlett NG
    PLoS One; 2013; 8(11):e81387. PubMed ID: 24278431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The carboxyl terminus of FANCE recruits FANCD2 to the Fanconi Anemia (FA) E3 ligase complex to promote the FA DNA repair pathway.
    Polito D; Cukras S; Wang X; Spence P; Moreau L; D'Andrea AD; Kee Y
    J Biol Chem; 2014 Mar; 289(10):7003-7010. PubMed ID: 24451376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
    Jacquemont C; Taniguchi T
    Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer.
    Platt-Higgins AM; Renshaw CA; West CR; Winstanley JH; De Silva Rudland S; Barraclough R; Rudland PS
    Int J Cancer; 2000 Mar; 89(2):198-208. PubMed ID: 10754500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons.
    Kachnic LA; Li L; Fournier L; Ferraiolo N; Dahm-Daphi J; Borgmann K; Willers H
    Cancer Lett; 2011 Jun; 305(1):86-93. PubMed ID: 21414716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
    Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
    Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication.
    Shen X; Do H; Li Y; Chung WH; Tomasz M; de Winter JP; Xia B; Elledge SJ; Wang W; Li L
    Mol Cell; 2009 Sep; 35(5):716-23. PubMed ID: 19748364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.
    Moes-Sosnowska J; Rzepecka IK; Chodzynska J; Dansonka-Mieszkowska A; Szafron LM; Balabas A; Lotocka R; Sobiczewski P; Kupryjanczyk J
    Cancer Biol Ther; 2019; 20(6):843-854. PubMed ID: 30822218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA robustly stimulates FANCD2 monoubiquitylation in the complex with FANCI.
    Sato K; Toda K; Ishiai M; Takata M; Kurumizaka H
    Nucleic Acids Res; 2012 May; 40(10):4553-61. PubMed ID: 22287633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Significance of
    Komatsu H; Masuda T; Iguchi T; Nambara S; Sato K; Hu Q; Hirata H; Ito S; Eguchi H; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
    Anticancer Res; 2017 Mar; 37(3):1083-1090. PubMed ID: 28314268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FANCD2 associated with sporadic breast cancer risk.
    Barroso E; Milne RL; Fernández LP; Zamora P; Arias JI; Benítez J; Ribas G
    Carcinogenesis; 2006 Sep; 27(9):1930-7. PubMed ID: 16679306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the Fanconi anemia pathway by a CUE ubiquitin-binding domain in the FANCD2 protein.
    Rego MA; Kolling FW; Vuono EA; Mauro M; Howlett NG
    Blood; 2012 Sep; 120(10):2109-17. PubMed ID: 22855611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
    Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF
    Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cells Deficient in the Fanconi Anemia Protein FANCD2 are Hypersensitive to the Cytotoxicity and DNA Damage Induced by Coffee and Caffeic Acid.
    Burgos-Morón E; Calderón-Montaño JM; Orta ML; Guillén-Mancina E; Mateos S; López-Lázaro M
    Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27399778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.
    Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D
    Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fanconi anemia D2 protein is an apoptotic target mediated by caspases.
    Park SJ; Beck BD; Saadatzadeh MR; Haneline LS; Clapp DW; Lee SH
    J Cell Biochem; 2011 Sep; 112(9):2383-91. PubMed ID: 21520247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing over-resection by DNA2 helicase/nuclease suppresses repair defects in Fanconi anemia cells.
    Karanja KK; Lee EH; Hendrickson EA; Campbell JL
    Cell Cycle; 2014; 13(10):1540-50. PubMed ID: 24626199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone chaperone activity of Fanconi anemia proteins, FANCD2 and FANCI, is required for DNA crosslink repair.
    Sato K; Ishiai M; Toda K; Furukoshi S; Osakabe A; Tachiwana H; Takizawa Y; Kagawa W; Kitao H; Dohmae N; Obuse C; Kimura H; Takata M; Kurumizaka H
    EMBO J; 2012 Aug; 31(17):3524-36. PubMed ID: 22828868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven.
    Wang Y; Wiltshire T; Senft J; Wenger SL; Reed E; Wang W
    Mol Cancer Ther; 2006 Dec; 5(12):3153-61. PubMed ID: 17172419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FANCD2 depletion sensitizes cancer cells repopulation ability in vitro.
    Lyakhovich A; Surralles J
    Cancer Lett; 2007 Oct; 256(2):186-95. PubMed ID: 17643815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.